Shionogi & Co. Ltd. (SGIOY)
PNK: SGIOY
· Real-Time Price · USD
8.30
-0.03 (-0.36%)
At close: May 01, 2025, 3:50 PM
-0.36% (1D)
| Bid | 8.27 |
| Market Cap | 14.12B |
| Revenue (ttm) | 423.36B |
| Net Income (ttm) | 150.1B |
| EPS (ttm) | 0.7 |
| PE Ratio (ttm) | 11.86 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 8.3 |
| Volume | 1,112 |
| Avg. Volume (20D) | 88,231 |
| Open | 8.29 |
| Previous Close | 8.33 |
| Day's Range | 8.27 - 8.31 |
| 52-Week Range | 6.22 - 8.72 |
| Beta | 0.15 |
About SGIOY
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-1...
Sector Healthcare
IPO Date Dec 1, 2015
Employees 4,959
Stock Exchange PNK
Ticker Symbol SGIOY
Website https://www.shionogi.com
